Objectives Inherited and acquired risk factors contribute to the development of the atherosclerotic lesion and its most common clinical manifestation, myocardial infarction (MI). Multiple studies have suggested a role for matrix metalloproteinases (MMPs) in atherosclerosis, and several functional polymorphisms in the MMP-1 gene have been linked to the risk of MI. The aim of this study was to evaluate the association between MMP-1 promoter polymorphisms and early MI in a Spanish cohort.
Introduction
Myocardial infarction (MI) is caused by several inherited and acquired risk factors that predispose to the development of atherosclerotic lesions and plaque rupture [1] . Degradation of the supporting elements of a coronary atherosclerotic plaque weakens its fibrous cap and thereby increases susceptibility to rupture. Matrix metalloproteinases (MMPs) disrupt the extracellular matrix, are present in atherosclerotic plaques, and seem to be more active in unstable lesions. Therefore, MMPs may play an important role in plaque rupture and the posterior remodeling of the vessel wall [2] . In particular, MMP-1 (collagenase-1) has been found in the shoulder of the atherosclerotic plaque, suggesting that an excess of collagenolitic activity could lead to an early plaque rupture [3] . Moreover, ApoE knockout mice expressing human MMP-1 had less advanced atherosclerotic lesions compared with their littermates that do not express MMP-1 [4] . In this way, MMP-1 could play a dual role in coronary artery disease (CAD): on one hand it favors the remodeling of the atherosclerotic lesions, but on the other hand, enhanced MMP-1 expression promotes plaque rupture [5] .
The MMP-1 is a candidate to modify the risk of atherosclerosis and MI in humans, and several polymorphisms have been analyzed through case-control studies. Most of them were focused on the 1G/2G insertion-deletion polymorphism at nucleotide position -1607. It has been reported that the insertion allele (2G) has increased gene transcription, compared with the deletion allele [6] . Homozygosis for the 2G allele has been associated with a lower risk for coronary heart disease in a Caucasian population [7] and haplotypes of 1G/2G MMP-1 (1G allele) and 5A/6A MMP-3 have been associated with increased risk of CAD, but not with MI [8] . Other studies could not find any association of this polymorphism with MI [9] .
Other genetic variants in the promoter have also been studied. Associations between haplotypes of the -519 A/G and -340 T/C polymorphisms and MI have been reported among British, Swedish, and Chinese populations [10, 11] , and the -519 A/G polymorphism has been associated with hypertension [12] , a conventional risk factor for CAD. Moreover, concrete haplotypes of these polymorphisms have been linked to increased promoter activities and higher levels of MMP-1 [10] , suggesting a relationship between these variants and the increased presence of this protein in atherosclerotic plaques.
Here, we analyzed the effect of these three functional promoter polymorphisms on MI risk in a group of Spanish male patients, all smokers, and who have suffered an early event of MI.
Methods

Patients and controls
We studied 261 unrelated male patients who have survived to a first episode of acute MI before 55 years of age. All these patients were diagnosed between 1998 and 2006 at our Cardiology Department, and MI was defined according to the World Health Organization criteria [13] . These patients underwent coronary angiography for diagnostic purposes, and had at least one atherosclerotic-diseased coronary vessel (a narrowing of > 30% of the vessel diameter). All the patients were recruited for a research project on the genetic factors involved in MI [14, 15] .
The control group consisted of 194 healthy male individuals, aged between 30 and 60 years, recruited through the Blood Bank at our Institution. These controls had not suffered episodes of cardiovascular disease, but they were not angiographically evaluated to exclude the presence of diseased coronary vessels, because coronary angiography is an invasive and potentially dangerous technique, only used for diagnostic/therapeutic purposes among patients with symptoms of CAD.
As early MI is strongly associated with smoking in our population, all the patients and controls were current or former smokers. Those with history of hypertension or a blood pressure greater than 140/90 mmHg in at least four determinations were considered as hypertensives. Those with a total cholesterol value greater than 200 mg/dl were considered as hypercholesterolemics. Patients with a history of diabetes or a basal glycemia greater than 120 mg/dl were excluded. Table 1 shows the main clinical, biochemical, and anthropometric characteristics of patients and controls.
All the participants were Caucasian males from the same region (Asturias, Northern Spain, total population 1 million), and gave their written informed consent to participate in the study, which was approved by the Ethics Committee of Clinical Investigation of Asturias.
MMP-1 polymorphisms genotyping
DNA was obtained from 10 ml of peripheral blood following a salting-out method [17] . The three polymorphisms [ -1607 1G/2G (rs11292517), -519 A/G (rs1144393), and -340 T/C (rs514921)] were genotyped through PCR-restriction fragment length polymorphism with the following conditions: 1 denaturing cycle at 951C for 3 min and 30 cycles at 951C for 30 s, annealing temperature (58, 62, and 601C, respectively) for 30 s, and 721C for 30 s. For -519 A/G, the fragment of 399 bp obtained with primers, forward 5 0 -TTA CAG AGA TGG GGT CTC AC-3 0 and reverse 5 0 -CCA TGG AGT ACT CTT TGA CC-3 0 , was digested with Kpn I. For -1607 1G/2G and -340 T/C, primers with a mismatch were designed: forward 5 0 -AAG TGT TCT TTG GTC TCT GC-3 0 , reverse 5 0 -GGA TTG ATT TGA GAT AAG TCA GAT C-3 0 , and forward 5 0 -TGT GTG GAG AAA CCT GTA GGA C-3 0 , reverse 5 0 -TCA CTT GGT GTT GCA ATG TC-3 0 , pairs for both single nucleotide polymorphisms, respectively (underlined are mismatched bases). The fragments of 176 and 209 bp were digested with Bgl II and Sau 96I, respectively, followed by electrophoresis on 3% agarose gels, and ethidium bromide staining to visualize the fragments.
Statistical analysis
The SPSS Statistical Package (v.12.0; SPSS Inc., Chicago, Illinois, USA) was used for the standard statistical comparisons. Continuous baseline characteristics were compared between the two groups using a Student's t-test, and categorical data with a w 2 test, which was also used to compare allele and genotype frequencies for each polymorphism and the deviation from Hardy-Weinberg equilibrium. Linkage disequilibrium coefficients (D 0 ) between polymorphisms were calculated with the SHEsis online program [18] , which was also used to estimate haplotype frequencies in both groups.
Results and discussion
Several studies suggested that MMP-1 prevents or delays the progression of atherosclerotic plaques. Null mice for TIMP-1 + ApoE and overexpressing human MMP-1 have less atherosclerotic lesions than expected, suggesting that MMP-1 could play a protective role in the progression of lesions [4] ; but the role of MMP-1 in the subsequent events of CAD, such as MI, or in carotid artery intima-media thickness, remains unclear [12] .
Our case-control study included 455 individuals, among which 261 were unrelated patients and 194 were healthy controls, sex and smoking status matched, with no differences in levels of total cholesterol, low-density lipoprotein-cholesterol, and triglycerides. However, we found statistically significant differences in some conventional risk factors such as age, number of hypertensives and hypercholesterolemics, and high-density lipoprotein-cholesterol levels ( Table 1 ). All the participants were genotyped for the -1607 1G/2G, -519 A/G, and -340 T/C MMP-1 polymorphisms, which were selected because they have been described to affect the transcription of the gene. The three polymorphisms were in Hardy-Weinberg equilibrium in patients and controls, and we found a weak linkage disequilibrium between -1607 1G/2G and -519 A/G (D 0 = 0.57), but not with the -340 C/T polymorphism.
We did not find significant differences in allelic or genotypic frequencies between both groups, for the three polymorphisms taken separately ( Table 2 ). These results are in agreement with earlier studies on 1G/2G polymorphism and MI risk, which reported no association of any genotype of this polymorphism and MI [10] , although some groups have found a reduced risk of coronary heart disease for carriers of the 2G -1607 allele [7] or a increased risk of CAD for the 1G -1607 allele [8] .
Another study have found an association between the single presence of the A allele of the -519 A/G polymorphism and the risk of acute coronary syndrome (ACS) [11] , but we did not find the same result.
There are also described haplotypic effects of the -519 A/G and -340 T/C polymorphisms on MI risk, with the A -519 -C -340 and G -519 -T -340 haplotypes being protective for MI in Caucasian population [10] , but A -519 -C -340 being of risk for ACS in Chinese population [11] . In our study, we could not find any effect for the G -519 -T -340 haplotype ( Table 3) , but we found a borderline protective effect of the A -519 -C -340 haplotype [odds ratio (OR) = 0.73; 95% confidence interval (95% CI) = 0.53-0.99; P = 0.045], supporting the earlier data on the Caucasian population and, although we found a trend to increase the risk of MI for the G -519 -C -340 haplotype as is described in British and Swedish patients [10] (OR = 1.45; 95% CI = 0.81-2.58), it does not reach statistical significance (Table 3 ). In addition, Han et al. [11] reported that the A -519 -T -340 haplotype significantly increased the risk of ACS, but we do not found any statistically significant protective effect for this combination ( Table 3 ).
The -1607 1G/2G is the most studied polymorphism in the MMP-1 gene, in part, because the 2G -1607 allele has over 20-fold higher transcriptional activity than 1G -1607 [6] . In our population, the G -519 -T -340 haplotype that has been described as protective for MI [10] is also protective, but only if it is forming a haplotype with the 1G -1607 allele (1G -1607 -G -519 -T -340 : OR = 0.68; 95% CI = 0.50-0.94; P = 0.02) ( Table 4 ). If the haplotype is with the 2G -1607 variant (the more active), it confers a significant risk of suffering MI (OR = 2.40; 95% CI = 1.27-4.55; P < 0.005). This effect is not only because of the -1607 1G/2G polymorphism, as neither the allelic nor the genotypic frequencies are statistically different in patients and controls (Table 2) . Therefore, it is necessary a specific haplotypic background with the Different studies showed that alleles linked to higher MMP-1 transcriptional activities would be associated with increased risk of MI and alleles with less activity would confer a protective effect [7, 10] . In our study, the protective effect of the haplotype is given when the three alleles with lower transcriptional activity are together, but the presence of a more active allele (2G -1607 ) and the less active haplotype G -519 -T -340 confers an increased risk of MI, suggesting that the associations are mainly driven by the -1607 1G/2G polymorphism and the -519 A/G and -340 T/C polymorphisms should be modifiers of the relationship. We cannot determine the effect of the haplotype with the more active alleles (2G -1607 -G -519 -C -340 ) because of its little frequency in our population (2%; Table 4 ), which does not allow the program to analyze it.
Finally, our study has some limitations. First, it was based on a limited number of cases and controls, although we analyzed a homogeneous population: Caucasian, male, smoker, nondiabetic, and below 60 years of age, younger than populations of other studies. Compared with other studies, hypercholesterolemics and hypertensives were underrepresented in our patients, and even these variables did not match in our groups, therefore we cannot exclude that this mask the effect of the MMP-1 polymorphisms on MI risk. In addition, the control group did not include individuals angiographically evaluated to confirm the absence of diseased vessels, although this could act underestimating our findings.
In conclusion, our data showed that concrete haplotypes of these three MMP-1 promoter polymorphisms have significant associations with early MI in smoking males, in a Northern Spanish population, where MI is strongly linked to this habit. The results suggest that this association is mainly driven by the -1607 1G/2G polymorphism, although with a background of a specific haplotype of -519 A/G and -340 T/C polymorphisms.
